Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. BA /
  3. MOLI.BA

Molinos Rio de la Plata SA (MOLI BA) stock market data APIs

ARS3805 -15(-0.4%) as of July 26, 2024
Price chart is built with Anychart

Molinos Rio de la Plata S.A. operates as a food company in Argentina. It operates through Food and Winery segments. The company offers noodles, soy milanesas, rice, breadcrumbs, premixes for gnocchi, pizza, chips and fried cake, frozen vegetables, and battered chicken under the Lucchetti brand; pastas under the Rina Matarazzo and Don Vicente brands; cutlets, nuggets, breaded foods, and sides under the Granja del Sol and Gallo brands; snacks under the Gallo Snacks brand; brownies, cookies, jellies, desserts, ice creams, and mousses under the Exquisita brand; empanadas, cakes and fresh pasta under La Saltena brand; noodles under the Favorita, Canale, Terrabusi, and Don Felipe brands; and breadcrumps under the Preferido brand. It also provides soups under the Vitina brand; coffee under the Arlistan and Richmond brand; virgin olive oil under the Lira brand; rice alfajores under Chocoarroz brand; Rica y Natural under Salus, Maximo, and chamigo brand; lemon juice under the Minerva brand; yerba products under the Cruz de Malta and Nobleza Gaucha brands; flour under the Blancaflor brand; and soy sauce, balsamic vinegar, corn oil, cooking oil, light salad dressing, and cooking spray under the Ideal, Cocinero brand. In addition, it offers wine under Nieto Senetiner, Cadus wines, and Ruca Malen brands. The company also exports its products. Molinos Rio de la Plata S.A. was founded in 1902 and is based in Victoria, Argentina.

Molinos Rio de la Plata SA Financial Data Overview

3820
3805
-
3940
3620
630-5550
761 477 M
10.8226
201 M
459 626 M
14.4039
1.084
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MOLI',
Type: 'Common Stock',
Name: 'Molinos Rio de la Plata SA',
Exchange: 'BA',
CurrencyCode: 'ARS',
CurrencyName: 'Argentine Peso',
CurrencySymbol: 'ARS',
CountryName: 'Argentina',
CountryISO: 'AR',
OpenFigi: NULL,
ISIN: 'ARP689251337',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Consumer Defensive',
Industry: 'Packaged Foods',
}

Molinos Rio de la Plata SA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 459 626 M
  • EBITDA 67 523 M
  • Earnings Per Share 349.27
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Molinos Rio de la Plata SA Earnings via APIs

  • Latest Release 2023-05-10
  • EPS/Forecast NaN

Get Molinos Rio de la Plata SA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Molinos Rio de la Plata SA latest news via APIs

Cyclo Therapeutics Receives Positive Opinion from the Paediatric Committee of the European Medicines Agency on the Agreement of a Paediatric Investigation Plan for Trappsol® Cyclo™

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation f...
  • BIOTECHNOLOGY COMPANY
  • DEVELOPMENT
  • EUROPE
  • EUROPEAN MEDICINES AGENCY
  • EUROPEAN UNION
  • PAEDIATRIC COMMITTEE
  • PAEDIATRIC INVESTIGATION PLAN
  • REGULATORY AUTHORITIES
  • THERAPEUTICS

Cyclo Therapeutics Receives Positive Opinion from the Paediatric Committee of the European Medicines Agency on the Agreement of a Paediatric Investigation Plan for Trappsol® Cyclo™

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation f...
  • BIOTECHNOLOGY COMPANY
  • DEVELOPMENT
  • EUROPE
  • EUROPEAN MEDICINES AGENCY
  • EUROPEAN UNION
  • PAEDIATRIC COMMITTEE
  • PAEDIATRIC INVESTIGATION PLAN
  • REGULATORY AUTHORITIES
  • THERAPEUTICS
Do you have any questions?
support@eodhistoricaldata.com